ATE332013T1 - Verbindungen für krebs-therapie - Google Patents

Verbindungen für krebs-therapie

Info

Publication number
ATE332013T1
ATE332013T1 AT99958453T AT99958453T ATE332013T1 AT E332013 T1 ATE332013 T1 AT E332013T1 AT 99958453 T AT99958453 T AT 99958453T AT 99958453 T AT99958453 T AT 99958453T AT E332013 T1 ATE332013 T1 AT E332013T1
Authority
AT
Austria
Prior art keywords
compounds
doxorubicin
cancer therapy
potency
presented
Prior art date
Application number
AT99958453T
Other languages
English (en)
Inventor
Oleg Strechenok
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900878A external-priority patent/SE9900878D0/xx
Priority claimed from SE9900941A external-priority patent/SE9900941D0/xx
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of ATE332013T1 publication Critical patent/ATE332013T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99958453T 1999-03-11 1999-12-28 Verbindungen für krebs-therapie ATE332013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900878A SE9900878D0 (sv) 1998-12-23 1999-03-11 New composition and use thereof
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use

Publications (1)

Publication Number Publication Date
ATE332013T1 true ATE332013T1 (de) 2006-07-15

Family

ID=26663529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958453T ATE332013T1 (de) 1999-03-11 1999-12-28 Verbindungen für krebs-therapie

Country Status (10)

Country Link
EP (1) EP1159756B1 (de)
JP (1) JP4643009B2 (de)
CN (1) CN1149219C (de)
AT (1) ATE332013T1 (de)
AU (1) AU766256B2 (de)
CA (1) CA2358420C (de)
DE (1) DE69932187T2 (de)
HK (1) HK1041889B (de)
ID (1) ID29246A (de)
WO (1) WO2000042832A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243701T1 (de) * 1999-03-16 2003-07-15 Ardenia Investments Ltd Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
US6699851B2 (en) 2000-07-12 2004-03-02 Ardenia Investments, Ltd. Cytotoxic compounds and their use
US6613753B2 (en) * 2001-02-21 2003-09-02 Supergen, Inc. Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
AUPR395801A0 (en) * 2001-03-26 2001-04-26 Austin Research Institute, The Antibodies against cancer
RU2240114C1 (ru) * 2003-04-03 2004-11-20 Ростовский научно-исследовательский онкологический институт МЗ РФ Способ лечения местных рецидивов рака шейки матки
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2018071679A1 (en) * 2016-10-13 2018-04-19 Carnot, Llc N-acylethanolamide derivatives and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04334377A (ja) * 1990-12-31 1992-11-20 Akzo Nv 酸−不安定性リンカー分子

Also Published As

Publication number Publication date
CA2358420A1 (en) 2000-07-27
DE69932187D1 (de) 2006-08-10
AU766256B2 (en) 2003-10-09
HK1041889A1 (en) 2002-07-26
AU1581800A (en) 2000-08-07
DE69932187T2 (de) 2007-05-24
CA2358420C (en) 2010-03-16
CN1332745A (zh) 2002-01-23
JP4643009B2 (ja) 2011-03-02
EP1159756B1 (de) 2006-06-28
ID29246A (id) 2001-08-16
WO2000042832A3 (en) 2001-02-01
EP1159756A2 (de) 2001-12-05
HK1041889B (zh) 2005-03-18
CN1149219C (zh) 2004-05-12
WO2000042832A2 (en) 2000-07-27
JP2002535251A (ja) 2002-10-22

Similar Documents

Publication Publication Date Title
ATE295347T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
SV1995000045A (es) Benzoxazolil- y benzotiazoliloxazolidinonas, ref. le a 30616-sv
AR019855A1 (es) Uso de conjugados de peg-ifn-alfa y ribavirina para la fabricacion de un medicamento para el tratamiento de hepatitis c cronica
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
ATE386808T1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
DE60335797D1 (de) Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
WO2000006134A3 (en) Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
AR032293A1 (es) Estuche farmaceutico
DE60134274D1 (en) Complex enthaltend modafinil und cyclodextrin
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
IL150528A0 (en) Ibuprofen containing active agent preparation
ATE332013T1 (de) Verbindungen für krebs-therapie
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
TR200103271T2 (tr) İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
MY128859A (en) Compounds for the treatment of cancer
AU4558201A (en) Taxane anticancer agents
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
HUP0202630A2 (hu) Meiózisra ható anyagokat tartalmazó készítmények
ATE340588T1 (de) Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
GB0128071D0 (en) Medicament
AU5825100A (en) Nitrates of bis-platinum complexes with polyamine ligands

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties